Metabolic phenotyping of human atherosclerotic plaques: Metabolic alterations and their biological relevance in plaque-containing aorta.

BACKGROUND AND AIMS Atherosclerosis is a chronic inflammatory disease characterized by thickening of the arterial wall. However, a limited number of studies have been conducted on metabolic profiling of human aortic tissue. METHODS We applied liquid chromatography/mass spectrometry to perform global and targeted profiling of plaque-containing aortic tissue. The aorta samples included plaque-containing (n = 18) and control plaque-free (n = 24) aortic tissue from patients undergoing aortic surgery. RESULTS The metabolic patterns of atherosclerotic and control vessels were significantly different. Metabolites in the purine and glutathione pathways showed dysregulation of oxidative stress in plaques, and levels of glucosylceramide, tryptophan, and kynurenine, which are related to inflammation, were also altered. Interestingly, an increased level of quinic acid was observed in plaques (p < 0.000), and we demonstrated an inhibitory effect of quinic acid on inflammatory activation and oxidative stress in macrophages. CONCLUSIONS Our study provides insight into the disease mechanism and potential markers of atherosclerosis through comprehensive metabolic profiling of human aortic tissue samples containing plaque.

[1]  Jian-Ping Zuo,et al.  Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro. , 2009, Antiviral research.

[2]  M. Davies,et al.  Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. , 2006, Free radical biology & medicine.

[3]  R. Draijer,et al.  Impact of short-term intake of red wine and grape polyphenol extract on the human metabolome. , 2012, Journal of agricultural and food chemistry.

[4]  C. di Ilio,et al.  Glutathione-related antioxidant defenses in human atherosclerotic plaques. , 1998, Circulation.

[5]  Robert S Plumb,et al.  Global metabolic profiling of animal and human tissues via UPLC-MS , 2012, Nature Protocols.

[6]  H. Kruth,et al.  Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Sullivan Iron in arterial plaque: modifiable risk factor for atherosclerosis. , 2009, Biochimica et biophysica acta.

[8]  D. Harrison,et al.  Role of oxidative stress in atherosclerosis. , 2003, The American journal of cardiology.

[9]  S. Chatterjee Sphingolipids in atherosclerosis and vascular biology. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[10]  K. Chida,et al.  Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.

[11]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[12]  A. Davies,et al.  Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis. , 2015, Journal of proteome research.

[13]  A. Orekhov,et al.  Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue. , 1989, European journal of biochemistry.

[14]  D. Raftery,et al.  Metabolomics-based methods for early disease diagnostics , 2008, Expert review of molecular diagnostics.

[15]  T. Lehtimäki,et al.  Activation of indoleamine 2,3-dioxygenase-induced tryptophan degradation in advanced atherosclerotic plaques: Tampere Vascular Study , 2010, Annals of medicine.

[16]  A. Davies,et al.  Metabolic Phenotypes of Carotid Atherosclerotic Plaques Relate to Stroke Risk: An Exploratory Study. , 2016, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[17]  F Santeusanio,et al.  Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study , 2000, Hypertension.

[18]  J. Michel,et al.  Metabolites secreted by human atherothrombotic aneurysms revealed through a metabolomic approach. , 2011, Journal of Proteome Research.

[19]  D. Fuchs,et al.  Immune activation and degradation of tryptophan in coronary heart disease , 2003, European journal of clinical investigation.

[20]  E. Bertini,et al.  Analysis of glutathione: implication in redox and detoxification. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[21]  S. Tyagi,et al.  Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle , 2004, Nutrition & metabolism.

[22]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[23]  G. Hwang,et al.  Lipidomic Profiling of Liver Tissue from Obesity-Prone and Obesity-Resistant Mice Fed a High Fat Diet , 2015, Scientific Reports.

[24]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[25]  J. Borén,et al.  Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation. , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[26]  D. Townsend,et al.  The importance of glutathione in human disease. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  J. Mehta,et al.  Oxidative stress in diabetes: a mechanistic overview of its effects on atherogenesis and myocardial dysfunction. , 2006, The international journal of biochemistry & cell biology.

[28]  F. Priego-Capote,et al.  Analysis of serum phospholipid profiles by liquid chromatography-tandem mass spectrometry in high resolution mode for evaluation of atherosclerotic patients. , 2014, Journal of chromatography. A.

[29]  A. Davies,et al.  Untargeted UPLC-MS Profiling Pipeline to Expand Tissue Metabolome Coverage: Application to Cardiovascular Disease , 2015, Analytical chemistry.

[30]  Ning Zhang,et al.  Plasma metabolomics reveals biomarkers of the atherosclerosis. , 2010, Journal of separation science.

[31]  G. Hutchins,et al.  Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. , 1997, Glycobiology.

[32]  R. Feinman,et al.  What is Nutrition & Metabolism? , 2004, Nutrition & Metabolism.

[33]  M. Davies,et al.  Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[34]  J. Egido,et al.  Improving metabolite knowledge in stable atherosclerosis patients by association and correlation of GC-MS and 1H NMR fingerprints. , 2009, Journal of proteome research.

[35]  B. Afşar,et al.  The role of uric acid in the pathogenesis of human cardiovascular disease , 2013, Heart.

[36]  A. Davies,et al.  Systems Biology of Human Atherosclerosis , 2014, Vascular and endovascular surgery.

[37]  D. Ramji,et al.  Interferon-g and atherosclerosis : Pro-or anti-atherogenic ? , 2005 .

[38]  T. Lehtimäki,et al.  Indoleamine 2,3‐dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study , 2007, Clinical and experimental immunology.

[39]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[40]  Yong Sup Lee,et al.  Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus. , 2006, Journal of natural products.

[41]  G. Hwang,et al.  LC/MS-based polar metabolite profiling reveals gender differences in serum from patients with myocardial infarction. , 2015, Journal of pharmaceutical and biomedical analysis.